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Objective. To examine patterns of hospitalisation for acute medical conditions in children with congenital adrenal hyperplasia
(CAH).Design. A retrospective study of hospitalisation using administrative data. Setting. All hospitals in NSW, Australia. Patients.
All patients admitted with CAH and a random sample of admissions in patients aged 0 to 18 years without adrenal insufficiency
(AI).Main Outcome Measures. Admissions and comorbidities by age and sex. Results. Of 573 admissions for medical problems in
CAH children, 286 (49.9%) were in males, and 236 (41.2%) had a principal diagnosis of CAH or had an adrenal crisis (AC). 37
(6.5%) ACs were recorded. An infection was found in 43.5% (𝑛 = 249) of the CAH patient admissions and 51.7% (𝑛 = 1613) of
the non-AI group, 𝑝 < 0.001. Children aged up to one year had the highest number of admissions (𝑛 = 149) and six ACs (four
in males). There were 21 ACs recorded for children aged 1–5 years. Older CAH children had fewer admissions and fewer ACs. No
in-hospital deaths were recorded. Conclusions. Admission for medical problems in CAH children declines with age. An AC was
recorded in 6.5% of the admissions, with the majority of ACs occurring in the 1 to 5 years age group and there were no deaths.
1. Introduction
Congenital adrenal hyperplasia (CAH) is the commonest
cause of adrenal insufficiency (AI) in childhood and 21-
hydroxylase deficiency is themost frequently occurring form,
accounting for approximately 95% of cases and having an
incidence of between 1 in 9,000 and 1 in 20,000 births [1–
3]. 21-Hydroxylase deficiency is autosomal recessive, with
patients inheriting inactivating mutations of varying severity
in both CYP21A2 alleles, resulting in impaired synthesis
and secretion of cortisol and aldosterone in combination
with elevated levels of adrenal androgens [3–5]. Patients,
particularly those with the more severe forms, are at risk
of a salt-wasting crisis in infancy and an adrenal crisis
(AC) at any age, when circulating cortisol levels are lower
than physiologically required, especially in conditions of
physiological stress such as infection [1, 3, 4].
Treatment of CAH involves glucocorticoid (GC) admin-
istration to provide GC replacement and to suppress ACTH
stimulation, thereby reducing excess adrenal androgen pro-
duction. Fludrocortisone is also used to treat aldosterone
deficiency. To suppress the production of adrenal androgens,
GC doses are often required in excess of physiological
replacement, which may impair growth and produce mani-
festations of GC excess [3–7]. Importantly, affected children
are also at increased risk of developing an AC, which may
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be fatal [4, 8–10], either due to reduced cortisol synthesis or
as a result of suppression of the hypothalamic-pituitary axis
due to therapeutic GC exposure.The incidence of AC in these
children is approximately 4.9 per 100 patient years [8].
Neonatal screening for 21-hydroxylase deficiency bymea-
surement of 17-hydroxyprogesterone, a steroid precursor
directly proximal to the 21-hydroxylase block, aims to prevent
ACs, which may be fatal, especially in males, but also in
females with mild or unrecognized genital virilization [1, 3,
11]. While screening programs are established in a number
of countries [12], screening is not available in Australia, nor
is there a national register of patients from which health
outcome data on patients affected by CAH can be extracted
and analysed. Hospital administrative datasets, however, are
accessible repositories of information on aspects ofmorbidity
in these patients and are particularly useful as a source of data
on serious morbidity in affected children beyond the early
infant period.The aim of this study, therefore, was to provide
further information on the burden of illness experienced by
CAH patients by examining patterns of hospitalisation for
acute medical (nonsurgical) problems in children with CAH
in Australia and to identify any factors that may be associated
with such hospitalisation in affected children.
2. Methods
New SouthWales (NSW) is a regionwith a population of over
7million people. All documented diseases and procedures for
each patient in NSW hospitals (public and private) are coded
according to the Australian modification of the International
Statistical Classification of Diseases and Related Problems
(diagnoses) [13] and are stored by the NSW Ministry of
Health. Cases were selected from all admissions between 2001
and 2013, in patients aged up to 18 years, where the principal
diagnosis (main reason for the admission) or any comorbid
diagnosis was CAH (E25.0). A second random sample of
all children (𝑛 = 3120), whose record did not contain any
codes for primary or secondary adrenal insufficiency (AI)
(non-AI group) and who had an admission for an acute
medical problem, was selected as a comparison sample of
patients. In both datasets, each record included patient age
(in years); sex; principal diagnosis; all secondary diagnoses
and procedures; admission to an intensive care unit (ICU);
and mortality. Exclusion criteria included malignant disease,
a principal diagnosis of psychiatric illness, or an obstetric or
gynaecological problem; admission for rehabilitation or for
planned day-only treatments or investigations such as dialysis
or endoscopy; patients awaiting transfer to another hospital;
admission for treatment of injuries; treatment of a surgical
complication; and admissions in which a surgical procedure
was performed.
An AC was identified by the code E27.2 in any diagnostic
field. Infection was classified as any diagnosis caused by an
organism such as a urinary tract infection (UTI), pneumonia,
or where an infectious agent was coded. Specifically, a virus
was identified where a viral agent was coded or where a
code indicated a virus (such as viral gastroenteritis). Bacterial
infections were identified in the same way. All UTIs (N39)
were classified as bacterial infections. Respiratory tract illness
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Figure 1: Total admissions, admissions for principal diagnosis of
CAH, and admissions with an adrenal crisis in patients with CAH,
NSW, 2000–2013.
was classified as any code relating to an acute problem in the
respiratory tract.
The study was approved by the Human Resource Ethics
Committee of the University of Notre Dame, Australia.
2.1. Statistical Analysis. Chi square and Fisher’s Exact tests
were used to assess the differences in frequencies of cate-
gorical variables between groups and 𝑡-tests were used to
determine the difference in continuous variables. The data
were analysed using SPSS (IBM Corp. released 2013, IBM
SPSS Statistics forWindows, Version 22.0., Armonk,NY, IBM
Corp.).
3. Results
During the thirteen-year study period, there were 573 admis-
sions for acute medical problems in children and adolescents
with CAH (corresponding to an average annual admission
rate of 44.1 admissions/year). There were 37 (6.5%) ACs
recorded. Half (𝑛 = 286, 49.9%) of the admissions were in
males (Table 1). Overall, there were 236 (41.2%) episodes of
hospitalisation for treatment of symptomatic hypoadrenal-
ism in this group, as either a principal diagnosis of CAH
(35.8%, 𝑛 = 205) or a record of an AC (5.4%, 𝑛 = 31)
but with an alternate principal diagnosis other than CAH.
Infants aged up to 12months contributed one-quarter (26.0%,
𝑛 = 149) of the admissions, with the number of admissions
decreasing with the increasing age of the children with
CAH (Figure 1). Children in the preschool (1 to 5 years) age
group contributed 207 admissions (36.1%) and there were 129
(22.5%) admissions in patients aged 6 to 11 years with the
remaining 15.4% (𝑛 = 88) aged 12 to 18 years. Infants had
the highest number of admissions with a principal diagnosis
of CAH (𝑛 = 83, 55.7%) (Figure 1). By comparison, children
aged between 1 and 5 years contributed the highest number
of ACs that were recorded (𝑛 = 21, 56.8%). No in-hospital
mortality was recorded among the CAH patients.
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Table 1: Demographic and disease characteristics of patients in the CAH and random sample groups, NSW, 2001–2013.
CAH group Random sample
𝑝 value(𝑛 = 573) (𝑛 = 3120)
𝑛 % 𝑛 %
Sex (male) 286 49.9 1703 54.6 <0.05
Age (mean) 5.1 (SD 5.2) 5.1 (SD 5.8) NS
Age group (yrs)
0 149 26.0 816 26.2 <0.001
1–5 207 36.1 1249 40.0
6–11 129 22.5 455 14.6
12–18 88 15.4 600 19.2
Length of stay (days)
1 333 58.1 1723 55.2 <0.05
2-3 140 24.4 933 29.9
4 or more 100 17.5 464 14.9
ICU admission 31 5.4 42 1.3 <0.001
Infection (any) 249 43.5 1613 51.7 <0.001
Bacteria 34 5.9 295 9.5 <0.01
Virus 122 21.3 632 20.3 NS
Respiratory tract illness 98 17.1 1207 38.7 <0.001
Asthma 22 3.8 422 13.5 <0.001
Bronchiolitis 13 2.3 266 8.5 <0.001
Pneumonia/LRTI 16 2.8 457 14.6 <0.001
Gastroenteritis 96 16.8 247 7.9 <0.001
UTI 15 2.6 116 3.7 NS
Fever 17 3.0 88 2.8 NS
Diabetes 2 0.3 83 2.7 <0.001
In contrast to the CAH children, a significantly greater
proportion of the random sample of non-AI children was
male (𝑛 = 1703, 54.6%; 𝑝 < 0.05) but the mean ages of the
two groupswere equal (mean (SD)CAH: 5.1 yrs (5.2), non-AI:
5.1 yrs (5.8)). The characteristics of the CAH and comparison
samples are shown in Table 1. The proportion of admissions
with an infection was significantly higher in the non-AI sam-
ple (51.7%, 𝑛 = 1613) than in the CAH patient group (43.5%,
𝑛 = 249) (𝑝 < 0.001). Viruses affected one-fifth of both
groups but CAH patients had fewer bacterial infections than
the comparison sample (CAH: 𝑛 = 34, 5.9%; non-AI 𝑛 = 295,
9.5%;𝑝 < 0.01). Respiratory tract illness anddiabetesmellitus
were significantly more common in the non-AI sample (both
𝑝 < 0.001). In contrast, gastroenteritis was significantly more
common among the children with CAH (𝑛 = 96, 16.8%) than
in the comparison group (𝑛 = 247, 7.9%) (𝑝 < 0.001).
Among the admissions of infants with CAH, 52.3% (𝑛 =
78) were inmales (Table 2). AnACwas recorded in six (4.0%)
admissions (four males) and a principal diagnosis of CAH
was present in 55.7% (𝑛 = 83) of the infants, suggesting
that symptomatic hypoadrenalism was the main reason for
admission in more than half the children in this age group.
Nearly one-fifth (𝑛 = 28, 18.8%) of the infants with CAH had
an admission to ICU, which was significantly more than the
proportion of infants in the random sample group in which
therewere 18 (2.2%) ICU admissions (𝑝 < 0.001). In addition,
ICU admission was significantly more common among male
than female infants in the CAH group (M: 𝑛 = 20, 25.6%; F:
𝑛 = 8, 11.3%; 𝑝 < 0.05). An infection was present in a third
of the admissions of infants in the CAH group (Table 2). In
this age group, males had significantly more infections (M:
𝑛 = 36, 46.2%; F: 𝑛 = 15, 21.1%; 𝑝 < 0.001) and respiratory
tract illnesses (M: 𝑛 = 13, 16.7%; F: 𝑛 = 4, 5.6%; 𝑝 < 0.05)
than females.
There were twenty-one (10.1%) ACs (13 females) identi-
fied in the 207 admissions in children with CAH who were
aged 1 to 5 years (Table 2). Half (50.7%, 𝑛 = 105) of these
children had an infection recorded, with 29.5% (𝑛 = 61)
having a viral and 3.4% (𝑛 = 7) having a bacterial infection
(Table 2). One-fifth (21.7%, 𝑛 = 45) of the CAH children
in this age group were diagnosed as having gastroenteritis
(Table 2). By comparison, among the 129 children aged
between 6 and 11 years, therewere only 5 (3.9%)ACs (4males)
recorded (Table 2). An infection was noted in 44.2% (𝑛 = 57)
of these children, and a viral infection (20.2%, 𝑛 = 26) was
more than three times as common as a bacterial infection
(6.2%, 𝑛 = 8).
In contrast, there were fewer patients (𝑛 = 88) admitted
to hospital in the 12 to 18 years age group and in this group
there were five ACs (5.7%) recorded (4 males) (Table 2). A
diagnosis of infection was found in 40.9% (𝑛 = 36) of this age
group, and like the situation in the younger children, viruses
(18.2%, 𝑛 = 16) were more common than bacterial (6.8%,
𝑛 = 6) infections.
4 International Journal of Endocrinology
Table 2: Comorbid conditions in patients with CAH by age, NSW, 2001–2013.
Up to 1 year 1–5 years 6–11 years 12–18 years
Admissions (𝑛) (149) (207) (129) (88)
𝑛 (%) 𝑛 (%) 𝑛 (%) 𝑛 (%)
Sex (males) 78 (52.3) 95 (45.9) 64 (49.6) 49 (55.7)
AC or CAH∗ 85 (57.0) 69 (33.3) 57 (44.2) 25 (28.4)
Adrenal crisis 6 (3.6) 21 (9.5) 5 (3.9) 5 (5.7)
CAH∗ 83 (55.7) 50 (24.2) 52 (40.3) 20 (22.7)
ICU admission 28 (18.8) 1 (0.5) 1 (0.8) 1 (1.1)
Any infection 51 (34.2) 105 (50.7) 57 (44.2) 36 (40.9)
Viral infection 19 (12.8) 61 (29.5) 26 (20.2) 16 (18.2)
Bacterial infection 13 (8.7) 7 (3.4) 8 (6.2) 6 (6.8)
Gastroenteritis 15 (10.0) 45 (21.7) 23 (17.8) 13 (14.8)
Respiratory tract illness 17 (11.4) 41 (19.8) 22 (17.1) 18 (20.5)
Asthma — 9 (4.3) 8 (6.2) 5 (5.7)
Acute bronchiolitis 9 (6.0) 4 (1.9) — —
Pneumonia/LRTI# 7 (4.7) 8 (3.9) 1 (0.8) —
UTI 7 (4.7) 3 (1.4) 3 (2.3) 2 (2.3)
Fever 5 (3.4) 10 (4.8) 2 (1.6) —
Ambiguous genitalia 10 (6.7) 3 (1.4) — —
Fused labia — — — —
Clitoral abnormalities 2 (1.2) — — —
Hypoosmolality/hyponatraemia 7 (4.7) 1 (0.5) 1 (0.8) —
Hypoglycaemia 1 (0.7) 6 (2.9) — —
Hypotension — — — 2 (2.3)
Hypovolaemia 9 (6.0) 15 (7.2) 9 (7.0) 3 (3.4)
Hyperkalaemia 2 (1.3) — — —
Hypokalaemia 1 (0.7) 1 (0.5) — 1 (1.1)
Nausea and vomiting 4 (2.7) 31 (15.0) 10 (7.8) 11 (12.5)
Abdominal pain — 4 (1.9) 2 (1.6) 8 (9.1)
Syncope/collapse — — — 1 (1.1)
Prematurity/neonatal problems 37 (24.8) 2 (1.0) — —
Hypertension 13 (8.7) 4 (1.9) 2 (1.5) 4 (4.1)
Epilepsy/convulsions — 4 (1.9) — 9 (9.3)
Diabetes mellitus — — 1 (0.8) 1 (1.0)
Obesity — — — 3 (3.1)
Prec. puberty — 2 (1.0) 3 (2.3) 3 (3.1)
Short stature — 3 (1.4) 9 (6.8) 2 (2.1)
∗As a principal diagnosis.
#LRTI: lower respiratory tract infection.
4. Discussion
The results of the present study, which covered thirteen years
of admissions to both private and public hospitals in a large
geographic area for medical treatment of children with CAH,
demonstrated that infants had the highest admission rate
among the age groups; episodes of hospitalisation decreased
with increasing age; 6.5% of the admissions included a record
of anACbut if all cases of admission for hypoadrenalismwere
included, almost 50% were due to some degree of AI; there
was a lessening of the risk of AC beyond age of five; comorbid
viral infections were more common than bacterial infections;
and there were no in-hospital deaths.
Among all the CAH patient admissions, 149 were in
infants, which corresponded to an average of 11.5 admissions
in the infant age group for each year of the study. A pilot study
of neonatal screening, conducted in the same geographic
area between 1995 and 1997, found an incidence of 6 to
7 cases of classic CAH per year [2], suggesting that the
infants in the present study had, at most, an average of two
medical admissions each in their first year of life. Only six
ACs were recorded in these children’s admissions, which
was lower than the number expected from studies in other
unscreened populations [2, 8, 14]. However, more than half
(55.7%) had a principal diagnosis of CAH, suggesting that
a substantial proportion of infants in this population had
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symptomatic hypoadrenalism or salt-wasting coded as the
reason for admission rather than an AC or that virilization
was identified postnatally in an infant that had not yet exhib-
ited salt-wasting or an AC and that this resulted in hospital
admission. Nearly one-fifth (18.8%) of these infants required
ICU admission, indicating that a substantial proportion of
patients were significantly unwell during the admission.
Although there were slightly more admissions among
male (52% of the total) than female infants, it was not possible
in this analysis to assess whether the observed sex ratio
reflected the true incidence of CAH. Differences in detection,
morbidity at presentation (particularly the likelihood of
presentation with an AC), and mortality risk between male
and female infants with CAH have been identified in a
number of incidence studies [1, 11, 14–17]. While there was
no significant difference between the sexes in the proportion
of admissions with either an AC or a principal diagnosis of
CAH in this study, male infants with CAH appeared to suffer
greater levels of morbidity, as they had approximately twice
the number of infections, had three times the number of
admissions for respiratory problems, and were twice as likely
to be admitted to an ICU compared to female infants.
In this analysis, children in the one- to five-year age cate-
gory had the highest proportion ofACs of the four age groups.
While the reasons for the higher incidence of ACs at this age
are uncertain, the children with CAH in this age group had
more infections than children in other age categories, as was
the case in the comparison group.Viral infections, respiratory
tract illness, and gastroenteritis were the most common
comorbid illnesses recorded, suggesting that management of
stress dosing during intercurrent infection may have been
associated with the need for parenteral GC administration
and hospitalisation.The higher level of infections in both the
CAH and non-AI subjects may be a reflection of an increased
exposure to infection, especially viruses, as children in this
age group move into childcare and start formal education,
a phenomenon that may be confounded by the cessation of
breastfeeding at this age, and possibly highlighting the need
for increased vigilance around the management of CAH in
the context of intercurrent illness at this time.
Infections are a common reason for admission to hospital
in childhood, and at least one infectious illness was reported
in 43.5% of all the episodes of hospitalisation for children
with CAH included in this study, which was lower than the
proportion of admissions with an infection in the control
sample (51.7%). Infections are a known precipitant of an AC
in treated AI [18, 19]. In the children with CAH, viral illnesses
were much more frequent than bacterial infections, while,
among adults with AI, it has been demonstrated that bacterial
infections predominate [20–22]. In addition, gastroenteritis
and fever are frequently identified as precipitating factors for
an AC in patients with AI [18], but these were reported in
only 15.7% and 3.1% of the children, respectively. Despite this,
in the present study, admission with a comorbid condition
of gastroenteritis was significantly more common among
children with CAH than among those without AI. This is
most likely due to the need for hospitalisation in children
with CAH who are vomiting or have a diarrhoeal illness and
who are unable to absorb appropriate GC pharmacotherapy.
Patient and caregiver education about the need for stress
dosing, parenteral GCs, and hospital attendance in the event
of intercurrent illness are regarded as a mainstay of sick day
management in AI [23]. However, recent evidence suggests
that patient education does not necessarily prevent the
occurrence of an AC [19].
In adolescence, the provision of clinical services to CAH
patients changes, with the development of greater patient
autonomy and the move from the pediatric service environ-
ment with parental oversight to an adult service [24, 25].
In this study, adolescents had the lowest annual admission
rate, but more than one-quarter of the admissions were for
a principal diagnosis of hypoadrenalism, either as an AC
(𝑛 = 5) or for a principal diagnosis of CAH, indicating that
severe illness related to AI remains an issue for some CAH
patients into adolescence and adulthood. While adolescents
with CAH who are receiving GC pharmacotherapy are at
risk of an AC, there are a number of other problems that
may emerge in this age group such as poor attendance at
medical reviews, reduced medication adherence, and the
development of testicular adrenal rest tumours in males [6,
24, 25].
The new information arising from this study illustrates
the benefit of using available administrative data to evaluate
the morbidity experienced by patients with chronic diseases,
such as CAH. The dataset used in this analysis represents all
the acutemedical admissions of patients with CAH to all hos-
pitals in a large geographic area and is not, therefore, affected
by problems with selection bias and generalisability that are
an issue in many studies. The analysis was enhanced by the
inclusion of a randomly selected sample of admissions in
childrenwithoutAI. In both theCAHandnon-AI groups, the
clinical information that was used in the analysis represented
the diagnosis conferred by the treating clinician and was
obtained from the medical record. These data are subjected
to regular audits at both the hospital and departmental level
to ensure accuracy. By using data from all hospitals in this
way, this study demonstrated the utility of such analyses in
determining the burden of severe illness in rare diseases and
provided information on the changes in serious morbidity
experienced by children with CAH from diagnosis to the end
of childhood.
However, these data also have some limitations. Both the
type and severity of CAH were not captured in the dataset,
nor was the exact age (in days) at presentation of infants,
as the patient’s age at the time of admission was included
in terms of years of age. Moreover, these data are based on
episodes of care rather than on individual patient histories
and it is likely that some children were admitted more than
once for symptomatic AI or an AC, as has been demonstrated
in previous studies [8]. Further, patients in the CAH group
were selected on the basis of that diagnosis appearing as a
condition in the medical record, and some patient treatment
episodes may have been omitted if the diagnosis was not
recorded. While the data include all patients treated in NSW
hospitals, it is possible that some patients, especially those
living near state borders, were treated at interstate hospitals
and were, therefore, not included in the analysis [26]. In
addition, although there were no deaths recorded in hospital,
6 International Journal of Endocrinology
it is possible that there were deaths that were attributable to
an AC that occurred outside hospital.
In summary, the results of this population-based study
suggest that AC events occur in CAH with a frequency that
is up to that of AI in adults, with the 1–5-year age group at
particular risk, perhaps due to frequent viral infections. It is
possible that higher doses of glucocorticoids given to control
androgen excess may induce secondary AI and heighten the
risk of AC among some children. The low incidence of AC
in infants is unexpected but may be related to differences
in coding in this age group. In addition, this large study
did not identify any in-hospital AC related deaths in this
child/adolescent population without screening.
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